MEDFILAMENT LTDActive

Company number 11320840Private limited companyIncorporated 2018
⚠ Confirmation statement overdue. It was due on 8 Nov 2026.

Key figures

−£14,868+61.3%
Net assets 2024/25
-40 k-30 k-20 k-10 k010 k2019/202020/212021/222022/232023/242024/25

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 k4 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover—43,45214,7538,02041,603
Profit for the year—443-29,160-9,50523,597
Total assets1081,1369431
Total liabilities00000
Net assets / total equity104543-29,060-38,465-14,868
Average number of employees24411
Average pay (per year)—2,7715,056——

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

We provide business advise services to early-stage companies; we develop prototypes, support fundraising and investors engagements.

As described in the company's latest filed accounts.

Summary: MEDFILAMENT LTD

Company

MEDFILAMENT LTD is a private limited company registered with Companies House under company number 11320840. It was incorporated on 20 Apr 2018. Its status is active. The registered office is in London (NW3). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files micro-entity accounts. Turnover was £41,603. Profit for the year was £23,597. Net assets were −£14,868, up 61.3% on the previous year. Total assets were £1 and total liabilities £0. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

The company has 1 current director. One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 8 Nov 2026.